The 新澳门六合彩官网 participated in the annual CMS Qualified Clinical Data Registry (QCDR) self-nomination process for the Merit-based Incentive Payment System (MIPS) performance year 2023. The 新澳门六合彩官网 submitted the following quality measures for CMS consideration within the 2023 QCDR nomination package:
- 新澳门六合彩官网ad 15: Report Turnaround Time: Radiography.
- 新澳门六合彩官网ad 16: Report Turnaround Time: Ultrasound (Excluding Breast US).
- 新澳门六合彩官网ad 17: Report Turnaround Time: MRI.
- 新澳门六合彩官网ad 18: Report Turnaround Time: CT.
- 新澳门六合彩官网ad 19: Report Turnaround Time: PET.
- 新澳门六合彩官网ad 25: Report Turnaround Time: Mammography.
- 新澳门六合彩官网ad 34: Multi-Strata Weighted Average for Three CT Exam Types (Overall percent of CT exams for which dose length product is at or below the size-specific diagnostic reference level for CT abdomen-pelvis with contrast/single phase scan, CT chest without contrast/single phase scan and CT head/brain).
- 新澳门六合彩官网ad 36: Incidental Coronary Artery Calcification Reported on Chest CT.
- 新澳门六合彩官网ad 37: Interpretation of CT Pulmonary Angiography for Pulmonary Embolism.
- 新澳门六合彩官网ad 38: Use of Low Dose Cranial CT or MRI Examinations for Patients with Ventricular Shunts.
- 新澳门六合彩官网ad 40: Use of Structured Reporting in Prostate MRI.
- 新澳门六合彩官网ad 41: Use of Quantitative Criteria for Oncologic FDG PET Imaging.
- 新澳门六合彩官网ad 42: Surveillance Imaging for Liver Nodules <10mm in Patients at Risk for Hepatocellular Carcinoma.
Additionally, 新澳门六合彩官网 included nine measures licensed from the MSN Healthcare Solutions QCDR in our self-nomination. If approved, this suite of QCDR measures will become available for use by MIPS-eligible radiologists using the 新澳门六合彩官网 National Radiology Data Registry for meeting the MIPS quality measurement requirement. Over the coming months, CMS will release the results of the 新澳门六合彩官网 self-nomination in time for using the measures during the 2023 MIPS performance year.
Please visit the 新澳门六合彩官网 QCDR webpage for more information about MIPS reporting.